InvestorsHub Logo
Followers 6
Posts 305
Boards Moderated 0
Alias Born 02/20/2013

Re: None

Thursday, 07/24/2014 1:01:06 PM

Thursday, July 24, 2014 1:01:06 PM

Post# of 55251
This joint venture is in final clinical testing with access to the existing $650 Million/Annum North American spey market. Royalties to flow to Therapy Cells by December 2014. More news to follow!